FDA removes axi-cel limitations of use for primary CNS lymphoma
The US Food and Drug Administration (FDA) approved an update to the prescribing information for axicabtagene ciloleucel (Yescarta), removing the previous Limitations of
Cellular Therapy
Lymphoma
Aggressive B-Cell Lymphomas
News
Leukemia
Acute Lymphoblastic Leukemia
SOHO 2026
News
SOHO Insider Podcast
Society Updates
Public-private partnerships needed to sustain progress in blood cancer treatment
John DiPersio, MD, PhD, current president of SOHO and director of the Center for Gene and Cellular Immunotherapy at Washington University School of
Leukemia
Acute Lymphoblastic Leukemia
Lymphoma
T-Cell Lymphoma
News
FDA approves larger Nelarabine vial size for T-ALL and T-LBL
The United States Food and Drug Administration (FDA) has signed off on a new, larger vial size for Nelarabine Injection for adult and
Ambassador Program
News
Society Updates
Registration is open for 4th SOHO Israel Annual Meeting
SOHO Israel is pleased to announce that the 4th Annual SOHO Israel Meeting, held in conjunction with the 10th International Davidoff Conference, will
Lymphoma Roundtable
Lymphoma
Indolent B-Cell Lymphomas
Roundtable Discussions
Video Interviews
CELMoDs in the second-line setting in follicular lymphoma
In this video, the group discusses golcadomide's potential in relapsed or refractory follicular lymphoma, including combinations with rituximab in heavily pretreated patients, ongoing
Multiple Myeloma
News
FDA approves daratumumab, hyaluronidase-fihj, VRd in newly diagnosed myeloma
The US Food and Drug Administration (FDA) granted approval for daratumumab and hyaluronidase-fihj (Darzalex Faspro, Janssen Biotech, Inc.) to be used in combination
Myeloproliferative Neoplasms
Primary Myelofibrosis
News
FDA grants zavabresib orphan drug designation in myelofibrosis
The US Food and Drug Administration (FDA) has granted orphan drug designation to zavabresib (OPN-2853) for the treatment of myelofibrosis. The generic name
Ambassador Program
SOHO Asia 2026
News
Society Updates
1st SOHO Asia hopes to empower hematology community across Asia
Dr. Hsin-An Hou, a professor at National Taiwan University Hospital, shares his excitement about the regional impact of the inaugural SOHO Asia meeting,
Leukemia
Acute Lymphoblastic Leukemia
FDA grants breakthrough designation to CAR-T therapy sofi-cel
Sofi-cel, an allogeneic, off-the-shelf, CD7-targeted CAR-T cell therapy, has previously received regenerative medicine advanced therapy, fast track, orphan drug, and rare pediatric disease
Multiple Myeloma
News
FDA clears IND for KLN-1010 in relapsed or refractory myeloma
The United States Food and Drug Administration cleared the Investigational New Drug application for KLN-1010, an in vivo BCMA-targeted CAR-T therapy, for patients